Leukemia Stem Cells in Hematologic Malignancies -

Leukemia Stem Cells in Hematologic Malignancies

Haojian Zhang, Shaoguang Li (Herausgeber)

Buch | Softcover
229 Seiten
2020 | 1st ed. 2019
Springer Verlag, Singapore
978-981-13-7344-2 (ISBN)
106,99 inkl. MwSt
This book introduces readers to the biology of leukemia stem cells (LSCs) and emphasizes the necessity and importance of targeting LSCs in the treatment of hematopoietic malignancies. It addresses the role of leukemia stem cells in different leukemia diseases and molecular signatures, as well as the metabolic and epigenetic regulation of leukemia stem cell function. With regard to solid tumors, a significant number of blood cancers are believed to be derived from leukemia stem cells (LSCs), which are responsible for disease progression, relapse and drug resistance. Consequently, new therapeutic strategies need to be developed by focusing on the complete eradication of LSCs. Given its scope, the book offers a valuable asset for graduate students and scientists in the fields of cell biology and cancer research etc.

Dr. Haojian ZhangDr. Shaoguang Li

Role of leukemia stem cells in pathogenesis of hematologic malignancies.- Leukemia stem cells in chronic myeloid leukemia.- Leukmeia stem cells in MLL-rearranged acute myeloid leukemia.- Interaction between leukmeia stem cells and bone marrow environment.- Molecular signatures of leukemia stem cells.- Metabolic regulation of leukemia stem cell function.- Epigenetic regulation of leukmeia stem cell function.- DNA instability and leukemia stem cell function.- Tumor suppressor genes in leukemia stem cells.- Targeting leukemia stem cells.- Leukemia stem cells and drug resistance.- Hypoxia and leukemia.

Erscheinungsdatum
Reihe/Serie Advances in Experimental Medicine and Biology ; 1143
Zusatzinfo 37 Illustrations, color; 3 Illustrations, black and white; VIII, 229 p. 40 illus., 37 illus. in color.
Verlagsort Singapore
Sprache englisch
Maße 155 x 235 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Studium
Naturwissenschaften Biologie Genetik / Molekularbiologie
Schlagworte blood cancer • disease relapse • drug resistance • leukemia stem cells • targeted therapy
ISBN-10 981-13-7344-2 / 9811373442
ISBN-13 978-981-13-7344-2 / 9789811373442
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
27,00
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
36,00